AZD7687

DRUG3 trials

Sponsors

AstraZeneca

Conditions

HealthyObeseObesityOverweightType 2 Diabetes

Phase 1

A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687

CompletedNCT01046357

AstraZenecaHealthy

Start: 2009-11-30End: 2010-06-30Target: 64Updated: 2012-02-13

AZD7687 Multiple Ascending Dose Study

CompletedNCT01119352

AstraZenecaObese, Overweight

Start: 2010-04-30End: 2011-03-31Updated: 2012-01-19

Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687

CompletedNCT01217905

AstraZenecaObesity, Type 2 Diabetes

Start: 2010-11-30End: 2011-07-31Target: 36Updated: 2012-02-13